Articles tagged with Enzyme Linked Immunosorbent Assays
Xiaohu Xia's research focuses on enhancing diagnostic efficacy of enzyme-linked immunosorbent assay (ELISA) testing using specially tailored nickel-platinum nanoparticles. His goal is to improve disease detection accuracy by more than 300 times, enabling early diagnosis of cancers like prostate and colorectal cancer.
Researchers have developed a highly sensitive immuno-CRISPR assay to detect acute kidney rejection in urine, potentially allowing for early diagnosis without invasive biopsy. The test uses CRISPR/Cas12a gene editing technology to identify biomarkers of rejection, such as CXCL9, with improved sensitivity compared to existing methods.
Researchers at the University of South Florida have developed a mobile version of ELISA, enabling point-of-care testing in doctor's offices and clinics. The new MELISA device measures progesterone levels and other hormones, making biomedical testing simple and affordable.